148 related articles for article (PubMed ID: 7955564)
61. Modulation of natural killer (NK) receptors on NK (CD3-/CD56+), T (CD3+/CD56-) and NKT-like (CD3+/CD56+) cells after heart transplantation.
Aguilar P; Mathieu CP; Clerc G; Ethevenot G; Fajraoui M; Mattei S; Faure GC; Bene MC
J Heart Lung Transplant; 2006 Feb; 25(2):200-5. PubMed ID: 16446221
[TBL] [Abstract][Full Text] [Related]
62. Defective mitogen-induced cellular cytotoxicity in myelodysplastic syndromes. Recovery after alpha-interferon administration.
Eliopoulos G; Constantopoulou M; Coulocheri S; Vaiopoulos G; Eliopoulos A; Yataganas X
Anticancer Res; 1991; 11(2):685-9. PubMed ID: 2064322
[TBL] [Abstract][Full Text] [Related]
63. Changes of natural killer cells' phenotype in patients with chronic hepatitis B in intermittent interferon therapy.
Bi X; Xie S; Wu S; Cao W; Lin Y; Yang L; Jiang T; Deng W; Wang S; Liu R; Gao Y; Shen G; Chang M; Hao H; Xu M; Chen X; Hu L; Lu Y; Zhang L; Xie Y; Li M
Front Immunol; 2023; 14():1116689. PubMed ID: 36793722
[TBL] [Abstract][Full Text] [Related]
64. Upregulation of NKG2C+ natural killer cells, TLR-2 expression on monocytes and downregulation of regulatory T-cells influence PEG-IFN treatment efficacy in entecavir-suppressed patients with CHB.
Yan W; Wu D; Wang X; Chen T; Lai Q; Zheng Q; Jiang J; Hou J; Han M; Ning Q
Antivir Ther; 2015; 20(6):591-602. PubMed ID: 25814467
[TBL] [Abstract][Full Text] [Related]
65. Abnormalities in the T and NK lymphocyte phenotype in patients with Nijmegen breakage syndrome.
MichaĆkiewicz J; Barth C; Chrzanowska K; Gregorek H; Syczewska M; Weemaes CM; MadaliĆski K; Stachowski J;
Clin Exp Immunol; 2003 Dec; 134(3):482-90. PubMed ID: 14632755
[TBL] [Abstract][Full Text] [Related]
66. Alpha interferon in the treatment of chronic hepatitis C infection in thalassaemia major.
Donohue SM; Wonke B; Hoffbrand AV; Reittie J; Ganeshaguru K; Scheuer PJ; Brown D; Dusheiko G
Br J Haematol; 1993 Mar; 83(3):491-7. PubMed ID: 8387324
[TBL] [Abstract][Full Text] [Related]
67. Effect of dietary ribonucleotides on infant immune status. Part 2: Immune cell development.
Buck RH; Thomas DL; Winship TR; Cordle CT; Kuchan MJ; Baggs GE; Schaller JP; Wheeler JG
Pediatr Res; 2004 Dec; 56(6):891-900. PubMed ID: 15496603
[TBL] [Abstract][Full Text] [Related]
68. [The interrelation of the expression of HLA class I and II proteins and of the costimulatory proteins CD11a/CD18 and CD16 with the lytic activity of resting and activated natural killer lymphocytes].
Musatov MI; Petrova ED; Konenkov VI
Tsitologiia; 1997; 39(7):617-28. PubMed ID: 9490502
[TBL] [Abstract][Full Text] [Related]
69. In vivo biological response to recombinant interferon-gamma during a phase I dose-response trial in patients with metastatic melanoma.
Kirkwood JM; Ernstoff MS; Trautman T; Hebert G; Nishida Y; Davis CA; Balzer J; Reich S; Schindler J; Rudnick SA
J Clin Oncol; 1990 Jun; 8(6):1070-82. PubMed ID: 2112184
[TBL] [Abstract][Full Text] [Related]
70. Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection.
Jinushi M; Takehara T; Kanto T; Tatsumi T; Groh V; Spies T; Miyagi T; Suzuki T; Sasaki Y; Hayashi N
J Immunol; 2003 Feb; 170(3):1249-56. PubMed ID: 12538683
[TBL] [Abstract][Full Text] [Related]
71. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10.
Goodier MR; Londei M
J Immunol; 2000 Jul; 165(1):139-47. PubMed ID: 10861046
[TBL] [Abstract][Full Text] [Related]
72. Serum levels of soluble interferon Alfa/Beta receptor as an inhibitory factor of interferon in the patients with chronic hepatitis C.
Mizukoshi E; Kaneko S; Kaji K; Terasaki S; Matsushita E; Muraguchi M; Ohmoto Y; Kobayashi K
Hepatology; 1999 Nov; 30(5):1325-31. PubMed ID: 10534358
[TBL] [Abstract][Full Text] [Related]
73. Natural Killer Group 2A Expressed on Both Peripheral CD3
Yi RT; Niu YH; Liu HL; Zhang TY; Yang YC; Zhang Y; Yin DL; Chen TY; Zhao YR
J Interferon Cytokine Res; 2016 Dec; 36(12):689-697. PubMed ID: 27828717
[TBL] [Abstract][Full Text] [Related]
74. [Changes and clinical significance of peripheral blood natural killer cells in neonates with bacterial pneumonia].
Li Q; Weng K; Zhu L; Mei X; Xu L; Lin J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1067-70. PubMed ID: 25270210
[TBL] [Abstract][Full Text] [Related]
75. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
[TBL] [Abstract][Full Text] [Related]
76. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
[TBL] [Abstract][Full Text] [Related]
77. Elevated levels of 2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells and serum during acute exacerbation of chronic hepatitis B.
Shindo M; Okuno T; Arai K; Matsumoto M; Takeda M; Takino T; Sokawa Y
Hepatology; 1989 May; 9(5):715-9. PubMed ID: 2468593
[TBL] [Abstract][Full Text] [Related]
78. 2',5'-Oligoadenylate synthetase activity in peripheral blood lymphocytes as a clinical marker in interferon therapy for chronic hepatitis B.
Furuta M; Akashi K; Nakamura Y; Matsumoto K; Yamaguchi H; Takamatsu S; Shimizu T
J Interferon Res; 1987 Feb; 7(1):111-9. PubMed ID: 3585079
[TBL] [Abstract][Full Text] [Related]
79. alpha-Interferon treatment of patients with chronic fatigue syndrome.
See DM; Tilles JG
Immunol Invest; 1996; 25(1-2):153-64. PubMed ID: 8675231
[TBL] [Abstract][Full Text] [Related]
80. In vitro and in vivo effect of interleukin-2 on the 2',5'-oligoadenylate synthetase activity of peripheral mononuclear blood cells.
Handgretinger R; Bruchelt G; Kimmig A; Lang P; Daurer B; Dopfer R; Treuner J; Niethammer D
J Interferon Res; 1990 Feb; 10(1):75-82. PubMed ID: 2109781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]